PMV Pharmaceuticals, Inc. PMVP
Set alert
1.37 USD +0.06 +4.58%
At close · Nov 2
1.24 -0.13 -9.49%
After hours · Nov 2, 4:00 PM ET
1.33 Day range 1.40
1.02 52-week range 1.91
- YTD
- +9.60%
- 1 year
- -2.84%
- Open
- 1.31
- Prev close
- 1.31
- Mkt cap
- 103.45M
- Vol
- 440.42K
- Avg vol
- 686.55K
- EPS
- -1.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.33
- High
- 1.40
- Forward P/E
- -0.96
- Beta
- 1.48
- Short ratio
- 5.17
- Inst. own
- 83.89%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.61
- 200-d avg
- 1.65
- 1y target
- 5.80
5D chart
Signals (50)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 10:45 AM | 17 hours ago |
| SMA: Bullish | Nov 2, 10:40 AM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 10:40 AM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 10:25 AM | 17 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 18 hours ago |
| RSI: Overbought | Oct 30, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:55 PM | 3 days ago |
| RSI: Overbought | Oct 30, 1:20 PM | 3 days ago |
| RSI: Oversold | Oct 30, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 3 days ago |
| RSI: Oversold | Oct 30, 10:10 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:50 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 1:45 PM | 4 days ago |
Newest 20 of 50.
Analyst view
Consensus: none
Price target (mean) 5.80 +323.4% upside
Now 1.37
- Target (low)
- 5.00
- Target (mean)
- 5.80
- Target (high)
- 7.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.3825 | -0.41 – -0.36 | -0.31 | -23.4% | 0 | 0.0% | 4 |
| Next quarter | -0.39 | -0.43 – -0.37 | -0.30 | -30.0% | 0 | 0.0% | 3 |
| Current year | -1.08 | -1.10 – -1.05 | -1.44 | +25.0% | 0 | 0.0% | 3 |
| Next year | -1.67 | -1.78 – -1.57 | -1.08 | -54.6% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | Craig-Hallum | Initiated | — | Buy |
| Apr 12, 2024 | Jefferies | Initiated | — | Buy |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 27, 2023 | Ladenburg Thalmann | Initiated | — | Buy |
| Oct 16, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 20, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2023 | Oppenheimer | Maintained | — | Outperform |
| Nov 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 9, 2022 | Oppenheimer | Maintained | — | Outperform |
| May 24, 2022 | Goldman Sachs | Maintained | — | Buy |
| Mar 2, 2022 | Oppenheimer | Upgrade | Perform | Outperform |
| Sep 22, 2021 | Goldman Sachs | Upgrade | Neutral | Buy |
| Aug 19, 2021 | Oppenheimer | Initiated | — | Perform |
| Aug 2, 2021 | Guggenheim | Initiated | — | Buy |
| Jul 29, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 20, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Oct 20, 2020 | B of A Securities | Initiated | — | Buy |
| Oct 20, 2020 | Goldman Sachs | Initiated | — | Neutral |